---
title: "NEPTUNUS: The medical device business is less affected by centralized procurement, and the company's significant matters are still ongoing"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/224317741.md"
description: "NEPTUNUS stated in a survey that its medical device business is less affected by centralized procurement, with operating income exceeding 12 billion yuan in 2023. This business mainly sells well-known brands such as Boston Scientific and Johnson & Johnson through agency sales. The company also emphasized that significant matters are still in progress and will disclose relevant information in a timely manner according to laws and regulations"
datetime: "2025-01-08T12:24:30.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/224317741.md)
  - [en](https://longbridge.com/en/news/224317741.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/224317741.md)
generator: "portal-rs"
---

# NEPTUNUS: The medical device business is less affected by centralized procurement, and the company's significant matters are still ongoing

NEPTUNUS today received research visits from several institutions including Dongfang Caifu Securities and Deyuan Investment, as well as some individual investors. During the research activities, the company stated that its medical device segment primarily operates on an agency sales model, representing several well-known domestic and international brands such as Boston Scientific, Johnson & Johnson, and Mindray Medical. The company's medical device revenue for 2023 has exceeded 12 billion yuan. Compared to the pharmaceutical business, the medical device business is less affected by centralized procurement. In addition, the company has management and sales elites from leading industry firms such as Boston Scientific and Siemens, ensuring professionalism and advanced management concepts in the medical device field. Furthermore, the company is still undergoing significant matters and will fulfill its information disclosure obligations in a timely manner according to relevant laws and regulations

### Related Stocks

- [000078.CN](https://longbridge.com/en/quote/000078.CN.md)
- [300760.CN](https://longbridge.com/en/quote/300760.CN.md)
- [JNJ.US](https://longbridge.com/en/quote/JNJ.US.md)
- [002826.CN](https://longbridge.com/en/quote/002826.CN.md)
- [300143.CN](https://longbridge.com/en/quote/300143.CN.md)
- [600056.CN](https://longbridge.com/en/quote/600056.CN.md)
- [BSX.US](https://longbridge.com/en/quote/BSX.US.md)
- [002728.CN](https://longbridge.com/en/quote/002728.CN.md)
- [SIEGY.US](https://longbridge.com/en/quote/SIEGY.US.md)
- [600662.CN](https://longbridge.com/en/quote/600662.CN.md)
- [600420.CN](https://longbridge.com/en/quote/600420.CN.md)
- [300059.CN](https://longbridge.com/en/quote/300059.CN.md)
- [003020.CN](https://longbridge.com/en/quote/003020.CN.md)

## Related News & Research

- [Höegh Autoliners ASA Just Missed EPS By 9.5%: Here's What Analysts Think Will Happen Next](https://longbridge.com/en/news/306385955.md)
- [Results: NKT A/S Exceeded Expectations And The Consensus Has Updated Its Estimates](https://longbridge.com/en/news/306385316.md)
- [Falcon Finance: Unlocks About 203 Million FF - Jul 2027](https://longbridge.com/en/news/306392750.md)
- [Falcon Finance: Schedules Unlock of About 203 Million FF - Jun 2027](https://longbridge.com/en/news/306392755.md)
- [Falcon Finance: Supply unlock releases about 203 million FF - May 2027](https://longbridge.com/en/news/306388616.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**